Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The International Journal of Cardiovascular Imaging|January 29, 2022
The diastolic function abnormalities in hemodialysis session: a two-dimensional speckle tracking echocardiographic (2DSTE) studyHakan Kosku, Cansin Tulunay Kaya, Sule Sengul, et al.Turkish Thoracic Journal|February 7, 2018
A Study Examining Compliance with the Anti-Tobacco Law Nb. 4207 Inside TaxisBurcu Öztürk, Hakan Kosku, İbrahim Güven, et al.Artificial Organs|April 13, 2020
Acute stunning effect of hemodialysis on myocardial performance: A three-dimensional speckle tracking echocardiographic studyHasan Selim Guler, Cansin Tulunay Kaya, Gizem Kumru, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 11, 2024
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative reviewSafa Can Efil, Burak Bilgin, Furkan Ceylan, et al.Journal of Clinical Medicine|February 27, 2026
Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter StudyMehmet Cihan İcli, Deniz Can Guven, Arif Akyildiz, et al.Clinical Genitourinary Cancer|April 16, 2024
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, et al.Journal of Clinical Medicine|June 26, 2025
Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group StudySerhat Sekmek, Aysel Oguz, Melek Karakurt Eryilmaz, et al.Future Oncology (London, England)|October 17, 2025
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access programDeniz Tural, Oğuzcan Özkan, Eda Eylemer Mocan, et al.Cancers|June 26, 2026
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group StudyBahadır Köylü, Özde Melisa Celayir, Harun Muğlu, et al.Pageof 1